Bisoprolol to prevent adverse cardiac events (PACE) in COPD: a multicentre, double-blind, randomised, controlled, phase 3 trial

The Lancet Respiratory Medicine 2026

View at publisher
Authors: Christine R Jenkins, Allison Martin, Catherina L. Chang, Richard Beasley, Jérémy Wrobel, Vanessa M. McDonald, Claudia Dobler, Ian A. Yang, Claude S. Farah, Belinda Cochrane, Graham S. Hillis, Caroline Polak Scowcroft
+48 more Channa D Ranasinha, H. Asita de Silva, Ashutosh N Aggarwal, Laurent Billot, Anthony Devaux, Christopher Gianacas, Shane Galgey, Robert J. Hancox, Robert J. Hancox, Christine R. Jenkins, Allison Martin, Catherina L. Chang, Robert J. Hancox, Robert J. Hancox, Richard Beasley, Jérémy Wrobel, Vanessa M. McDonald, Claudia Dobler, Ian A. Yang, Claude S. Farah, Belinda Cochrane, Graham S. Hillis, Caroline Polak-Scowcroft, Channa D. Ranasinh, H. Asita de Silva, Ashutosh N Aggarwal, Laurent Billot, Anthony Deveaux, Christopher Gianacas, Shane Galgey, Lutz Beckert, Peter Bremner, Jack Dummer, Ben Brockway, Dhruva Chaudhry, Amitha Fernando, James Fingleton, Soo Wei Foo, Peter Gibson, Ravini Karunathilake, Christopher Kosky, Uma Maheswari Krishnaswamy, D Medagedara, Anant Mohan, Eshanth Perera, Pawan Kumar Singh, Siva Sivakumaran, Conroy Wong
DOI: 10.1016/s2213-2600(25)00390-x
Cited by: 9
References: 29

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory and Cough-Related Research Heart rate and cardiovascular health

Publication details

Journal / source
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Volume
14
Issue
3
Pages
203–214
Publication date
21 January 2026
Language
EN